Literature DB >> 15593354

Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.

Gábor Cserni1, Simonetta Bianchi, Werner Boecker, Thomas Decker, Manuela Lacerda, Fritz Rank, Clive A Wells.   

Abstract

BACKGROUND: The latest edition of the tumor-lymph node-metastasis (TNM) classification of malignant tumors distinguishes between isolated tumor cells (pN0) and micrometastases (pN1mi). The reproducibility of these categories has not been assessed previously.
METHODS: Digital images from 50 cases with low-volume lymph node involvement from axillary sentinel lymph nodes were circulated twice for evaluation (Evaluation Rounds 1 and 2) among the members of the European Working Group for Breast Screening Pathology, and the members were asked to categorize lesions as micrometastasis, isolated tumor cells, or something else and to classify each case into a pathologic lymph node (pN) category of the pathologic TNM system. Methods for improving the low reproducibility of the categorizations were discussed between the two evaluation rounds. kappa Statistics were used for the assessment of interobserver variability.
RESULTS: The kappa value for the consistency of categorizing low-volume lymph node load into micrometastasis, isolated tumor cells, or neither of those changed from 0.39 to 0.49 between Evaluation Rounds 1 and 2, but it was slightly lower for the pN categories (0.35 and 0.44, respectively). Interpretation of the definitions of isolated tumor cells (especially with respect to their localization within the lymph node), lack of guidance on how to measure them if they were multiple, and lack of any definitions for multiple simultaneous foci of lymph node involvement were listed among the causes of discordant diagnoses.
CONCLUSIONS: The results of the current study indicated that the definitions available have minor contradictions and do not permit a reproducible distinction between micrometastases and isolated tumor cells. Refinement of these definitions, therefore, is required. One refinement that may improve reproducibility is suggested in this report. (c) 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2005        PMID: 15593354     DOI: 10.1002/cncr.20760

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Further axillary metastases associated with isolated tumor cells in sentinel lymph nodes of breast cancer patients.

Authors:  Gabor Cserni
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Disseminated cancer cells in the bone marrow: are they really there at all?

Authors:  Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

Review 3.  Breast cancer and sentinel lymph node micrometastases: indications for lymphadenectomy and literature review.

Authors:  G Zanghì; G Di Stefano; A Caponnetto; R Vecchio; A Lanaia; A La Terra; V Leanza; F Basile
Journal:  G Chir       Date:  2014 Nov-Dec

Review 4.  Minimal disease in sentinel nodes.

Authors:  Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

5.  A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes.

Authors:  Steven J Hughes; Liqiang Xi; William E Gooding; David J Cole; Michael Mitas; John Metcalf; Rohit Bhargava; David Dabbs; Jesus Ching; Lynn Kozma; William McMillan; Tony E Godfrey
Journal:  J Mol Diagn       Date:  2009-10-01       Impact factor: 5.568

6.  Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Authors:  Hassan A Hatoum; Faek R Jamali; Nagi S El-Saghir; Khaled M Musallam; Muhieddine Seoud; Hani Dimassi; Jaber Abbas; Mohamad Khalife; Fouad I Boulos; Ayman N Tawil; Fadi B Geara; Ziad Salem; Achraf A Shamseddine; Karine Al-Feghali; Ali I Shamseddine
Journal:  Indian J Surg Oncol       Date:  2010-08-07

7.  Patients' choice on axillary lymph node dissection following sentinel lymph node micrometastasis--first report on prospective use of a nomogram in very low risk patients.

Authors:  Gábor Cserni; Istvánné Bezsenyi; László Markó
Journal:  Pathol Oncol Res       Date:  2012-10-16       Impact factor: 3.201

8.  The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.

Authors:  G Cserni; S Bianchi; V Vezzosi; H Peterse; A Sapino; R Arisio; A Reiner-Concin; P Regitnig; J-P Bellocq; C Marin; R Bori; J M Penuela; A Córdoba Iturriagagoitia
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

9.  Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer.

Authors:  P D Britton; A Goud; S Godward; S Barter; A Freeman; M Gaskarth; P Rajan; R Sinnatamby; J Slattery; E Provenzano; M O'Donovan; S Pinder; J R Benson; P Forouhi; G C Wishart
Journal:  Eur Radiol       Date:  2008-09-17       Impact factor: 5.315

10.  Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer.

Authors:  Mike Visser; Mehdi Jiwa; Anja Horstman; Antoinette A T P Brink; Rene P Pol; Paul van Diest; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.